Vanberra Signal

Augustinus Bader

Curated by Signal

Developer of personalized regenerative medicines for the prevention of diseases in humans and vets

Overview

Developer of personalized regenerative medicines for the prevention of diseases in humans and vets. These medicines help in the healing of damaged tissues and increase the nutrient supply in tissues. The company has developed medicine based on therapeutic cells such as endogenous stem cells to treat different diseases that occur in humans and animals such as horses and dogs.

Key facts

Founded
2017
Headquarters
United States

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of prosthetics for partial hand limb loss

    Life Sciences TechnologyWarren, United States
  • Surgical guidance systems for orthopedic surgeries

    Life Sciences TechnologySalt Lake City, United States
  • Developer novel therapeutics to treat resistant infectious diseases and cancers using AI

    Life Sciences TechnologyNew York City, United States

About Augustinus Bader

What does Augustinus Bader do?

Developer of personalized regenerative medicines for the prevention of diseases in humans and vets.

Where is Augustinus Bader headquartered?

Augustinus Bader is headquartered in United States.

When was Augustinus Bader founded?

Augustinus Bader was founded in 2017.

Which sector is Augustinus Bader in?

Augustinus Bader operates in Life Sciences Technology.

Who are Augustinus Bader's competitors?

Companies similar to Augustinus Bader include Partial Hand Solutions, OrthoGrid Systems, and Lodo Therapeutics.